Last but not least, CD8+ CTLs (Tc) recognize the tumor-specific antigen via interaction with T cell receptor (TCR) and the CSA presented on MHC-I cells, and then attack and destroy tumor cells via perforin and granzyme release (Figure 5). This evidence concerns the gene PRF1 and neoplasm.